Clinical Effectiveness and Cost-Effectiveness of HIV Pre-Exposure Prophylaxis in Men Who Have Sex with Men: Risk Calculators for Real-World Decision-Making

per Chen, Anders, Dowdy, David W.
Publicat 2014

Reply to Chen, Song, and Liu

per Hong, Hyejeong, Dowdy, David W
Publicat a Clin Infect Dis (2020)

Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees

per Ilaiwy, Ghassan, Dowdy, David W.
Publicat a J Clin Tuberc Other Mycobact Dis (2021)

The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection

per Dowdy, David W, Chaisson, Richard E
Publicat 2009

Author reply

per Dowdy, David W, Chaisson, Richard E
Publicat 2009

Post-2015 tuberculosis strategies in a pre-2015 world

per Dowdy, David W., Chaisson, Richard E.
Publicat a Int J Tuberc Lung Dis (2013)

Measuring success: The challenge of social protection in helping eliminate tuberculosis

per Shete, Priya B., Dowdy, David W.
Publicat a PLoS Med (2017)

Data Needs for Evidence-Based Decisions: A TB Modeler’s “Wish List”

per Dowdy, David W., Dye, Christopher, Cohen, Ted
Publicat 2013

Mathematical Modelling and Tuberculosis: Advances in Diagnostics and Novel Therapies

per Zwerling, Alice, Shrestha, Sourya, Dowdy, David W.
Publicat a Adv Med (2015)

Serological Testing Versus Other Strategies for Diagnosis of Active Tuberculosis in India: A Cost-Effectiveness Analysis

per Dowdy, David W., Steingart, Karen R., Pai, Madhukar
Publicat 2011

Is Passive Diagnosis Enough?: The Impact of Subclinical Disease on Diagnostic Strategies for Tuberculosis

per Dowdy, David W., Basu, Sanjay, Andrews, Jason R.
Publicat 2013

Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis?

per Denkinger, Claudia M., Pai, Madhukar, Dowdy, David W.
Publicat 2014

How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India

per Azman, Andrew S, Golub, Jonathan E, Dowdy, David W
Publicat a BMC Med (2014)

Costs and Consequences of Using Interferon-γ Release Assays for the Diagnosis of Active Tuberculosis in India

per Little, Kristen M., Pai, Madhukar, Dowdy, David W.
Publicat a PLoS One (2015)

Cost-Consequence Analysis of Multimodal Interventions with Environmental Components for Pediatric Asthma in the State of Maryland

per Jassal, Mandeep S., Diette, Gregory B., Dowdy, David W.
Publicat a J Asthma (2013)

Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis

per Kendall, Emily A, Fojo, Anthony T, Dowdy, David W
Publicat a Lancet Respir Med (2017)

The Epidemiological Importance of Subclinical Tuberculosis. A Critical Reappraisal

per Kendall, Emily A., Shrestha, Sourya, Dowdy, David W.
Publicat a Am J Respir Crit Care Med (2021)

Cost-Effectiveness of Novel First-Line Therapeutic Regimens for Tuberculosis

per Owens, Jonathan P., Fofana, Mariam O., Dowdy, David W.
Publicat 2013

The Impact of Novel Tests for Tuberculosis Depends on the Diagnostic Cascade

per Sun, Amanda Y., Denkinger, Claudia M., Dowdy, David W.
Publicat a Eur Respir J (2014)

The burden of transmitted multi-drug resistance among epidemics of tuberculosis: A transmission model

per Kendall, Emily A., Fofana, Mariam O., Dowdy, David W.
Publicat a Lancet Respir Med (2015)